In 2002 Sportmeda Ltd (previously PC Farmakoekonomikos centras) introduced the service of pharmacoeconomic analysis to the Lithuanian market.

 The goal of pharmacoeconomic analysis is to provide an overview of scientific research published on the pharmaceutical concerning the comparison of the pharmaceutical's clinical effectiveness and the results of its pharmacoeconomic assessment when compared to the pharmaceutical's main alternative; analyse the actual use of the pharmaceutical and connected health care costs in Latvia using various databases of Lithuanian Health Insurance Fund; predict changes in health care costs when a currently used pharmaceutical is going to be exchanged for a new one using the methods of pharmacoeconomic analysis and based on the results of published research.

 Sportmeda Ltd experts have over 18 years of experience in health economics field, that can be utilized for making knowledgeable decisions about your products. Our expertise in health economics and outcomes research can provide informative evidence to decision makers regarding the value of your product in the marketplace.

We work with many of the largest global pharmaceutical companies.

We gladly conduct pharmacoeconomic analyses also on other markets where the economic assessment of pharmaceuticals is necessary for introducing a pharmaceutical to the market.

We offer:
 - Pharmacoeconomic evaluations for Lithuanian market;
 - Preparation of all documents for the reimbursement of medicines for Lithuanian market;
 - Market analysis;
 - Consultations pharmaceutical reimbursement issues

If you are interested in our services, please contact us.